ATEC
Price
$7.47
Change
+$0.16 (+2.19%)
Updated
Nov 3 closing price
Capitalization
1.15B
118 days until earnings call
Intraday BUY SELL Signals
IRMD
Price
$81.11
Change
+$1.69 (+2.13%)
Updated
Nov 3 closing price
Capitalization
1.04B
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATEC vs IRMD

ATEC vs IRMD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ATEC vs. IRMD commentary
Nov 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEC is a Hold and IRMD is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ATEC with price predictions
Nov 03, 2026

ATEC's RSI Indicator sits in oversold zone for 2 days

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +6.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATEC advanced for three days, in 265 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

ATEC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 195 of 253 cases where ATEC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ATEC as a result. In 72 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.

The Moving Average Convergence Divergence Histogram (MACD) for ATEC turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 29 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

ATEC moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ATEC crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATEC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ATEC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ATEC's P/B Ratio (-95.596) is very low in comparison to the industry average of (4.170). P/E Ratio (-10.521) is within average values for comparable stocks, (1.500). ATEC's Projected Growth (PEG Ratio) (91.200) is very high in comparison to the industry average of (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (1.980) is also within normal values, averaging (40.124).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATEC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for IRMD with price predictions
Nov 03, 2026

IRMD's RSI Indicator ascending out of oversold territory

The RSI Oscillator for IRMD moved out of oversold territory on November 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 16 similar instances when the indicator left oversold territory. In 14 of the 16 cases the stock moved higher. This puts the odds of a move higher at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +5.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in 193 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

IRMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 214 of 265 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IRMD as a result. In 71 of 114 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.

The Moving Average Convergence Divergence Histogram (MACD) for IRMD turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 29 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.

IRMD moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IRMD crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.193) is normal, around the industry mean (4.170). P/E Ratio (44.812) is within average values for comparable stocks, (1.500). Projected Growth (PEG Ratio) (1.180) is also within normal values, averaging (11.253). Dividend Yield (0.010) settles around the average of (0.010) among similar stocks. P/S Ratio (12.315) is also within normal values, averaging (40.124).

FUNDAMENTALS RATINGS
ATEC vs IRMD: Fundamental Ratings
ATEC
IRMD
OUTLOOK RATING
1..100
6773
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10022
SMR RATING
1..100
10041
PRICE GROWTH RATING
1..100
6560
P/E GROWTH RATING
1..100
3562
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRMD's Valuation (84) in the Medical Specialties industry is in the same range as ATEC (96). This means that IRMD’s stock grew similarly to ATEC’s over the last 12 months.

IRMD's Profit vs Risk Rating (22) in the Medical Specialties industry is significantly better than the same rating for ATEC (100). This means that IRMD’s stock grew significantly faster than ATEC’s over the last 12 months.

IRMD's SMR Rating (41) in the Medical Specialties industry is somewhat better than the same rating for ATEC (100). This means that IRMD’s stock grew somewhat faster than ATEC’s over the last 12 months.

IRMD's Price Growth Rating (60) in the Medical Specialties industry is in the same range as ATEC (65). This means that IRMD’s stock grew similarly to ATEC’s over the last 12 months.

ATEC's P/E Growth Rating (35) in the Medical Specialties industry is in the same range as IRMD (62). This means that ATEC’s stock grew similarly to IRMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATECIRMD
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
62%
MACD
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
54%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
81%
Bearish Trend 8 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
COMPARISON
Comparison
Nov 04, 2026
Stock price -- (ATEC: $7.47 vs. IRMD: $81.11)
Brand notoriety: ATEC and IRMD are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ATEC: 200% vs. IRMD: 133%
Market capitalization -- ATEC: $1.15B vs. IRMD: $1.04B
ATEC [@Medical/Nursing Services] is valued at $1.15B. IRMD’s [@Medical/Nursing Services] market capitalization is $1.04B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $189.3B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATEC’s FA Score shows that 0 FA rating(s) are green while IRMD’s FA Score has 1 green FA rating(s).

  • ATEC’s FA Score: 0 green, 5 red.
  • IRMD’s FA Score: 1 green, 4 red.
According to our system of comparison, IRMD is a better buy in the long-term than ATEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATEC’s TA Score shows that 5 TA indicator(s) are bullish while IRMD’s TA Score has 5 bullish TA indicator(s).

  • ATEC’s TA Score: 5 bullish, 5 bearish.
  • IRMD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ATEC and IRMD are a good buy in the short-term.

Price Growth

ATEC (@Medical/Nursing Services) experienced а -31.28% price change this week, while IRMD (@Medical/Nursing Services) price change was -3.38% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.01%. For the same industry, the average monthly price growth was -7.51%, and the average quarterly price growth was -8.84%.

Reported Earning Dates

ATEC is expected to report earnings on Mar 02, 2027.

IRMD is expected to report earnings on Feb 04, 2027.

Industries' Descriptions

@Medical/Nursing Services (-2.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ATEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATEC has been loosely correlated with SIBN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ATEC jumps, then SIBN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATEC
1D Price
Change %
ATEC100%
+2.19%
SIBN - ATEC
55%
Loosely correlated
+17.56%
TMDX - ATEC
45%
Loosely correlated
+1.00%
OFIX - ATEC
45%
Loosely correlated
+0.11%
ENOV - ATEC
39%
Loosely correlated
+1.31%
PODD - ATEC
38%
Loosely correlated
+0.81%
More

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+2.13%
HBIO - IRMD
45%
Loosely correlated
+0.81%
PHG - IRMD
42%
Loosely correlated
+3.15%
TWST - IRMD
41%
Loosely correlated
+8.73%
ATEC - IRMD
40%
Loosely correlated
+2.19%
ICUI - IRMD
40%
Loosely correlated
-0.34%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRNQ6.500.60
+10.17%
Greenpro Capital Corp
CYD22.190.16
+0.73%
China Yuchai International Ltd
WTW327.662.15
+0.66%
Willis Towers Watson Public Limited
AVNT43.25-0.20
-0.46%
Avient Corp
FLWS2.70-0.04
-1.46%
1-800-FLOWERS.COM